Kuangli Bio-Tech Holdings Co., Ltd.

TWSE:6431 Stock Report

Market Cap: NT$1.8b

Kuangli Bio-Tech Holdings Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jing-Xiang Lin

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.1yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure7.2yrs

Recent management updates

Recent updates

Analysis Article • Feb 25

Kuangli Bio-Tech Holdings Co., Ltd. (TWSE:6431) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Kuangli Bio-Tech Holdings Co., Ltd. ( TWSE:6431 ) shareholders would be excited to see that the share price has had a...
Analysis Article • Mar 22

Kuangli Bio-Tech Holdings Co., Ltd.'s (TWSE:6431) Shareholders Might Be Looking For Exit

When close to half the companies in the Electronic industry in Taiwan have price-to-sales ratios (or "P/S") below 1.6x...
Analysis Article • Mar 31

We're Not Worried About Kuangli Photoelectric Technology's (TPE:6431) Cash Burn

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Analysis Article • Feb 03

Did Business Growth Power Kuangli Photoelectric Technology's (TPE:6431) Share Price Gain of 248%?

When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...
Analysis Article • Dec 09

We Think Kuangli Photoelectric Technology (TPE:6431) Can Easily Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

CEO

Jing-Xiang Lin

1.1yrs
Tenure

Jing-Xiang Lin is President of Kuangli Bio-Tech Holdings Co. Ltd. from May 29, 2025.

Board Members

NamePositionTenureCompensationOwnership
Qinglian Zhang
Manager & Director7.2yrsno data1.41%
NT$ 25.6m
Ming Tang Cai
Independent Directorno datano datano data
Shifang Qiu
Independent Director7.2yrsno datano data
Qinghui Zhang
Director7.2yrsno datano data
Minzheng Liao
Director7.2yrsno datano data
Huixian Wang
Independent Director7.2yrsno datano data
Qing-Lian Zhang
Directorno datano datano data
Kuan-Tsong Chen
Representative Directorno datano datano data
Jia-Wei Wang
Representative Chairman1.1yrsno datano data
Yi-Sheng Yang
Independent Director1yrno datano data
Hsi-Lin Chiu
Independent Director1yrno datano data
Chia-Wei Wu
Independent Director1yrno datano data
7.2yrs
Average Tenure

Experienced Board: 6431's board of directors are considered experienced (7.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/12 21:41
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kuangli Bio-Tech Holdings Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.